ClearPoint Neuro, Inc. Common Stock (CLPT)

Price$12.64

Value ScoreF

Growth ScoreA

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-22.15%

Price vs S&P 500 (4W)6.46%

VGM Score51.36

Market Capitalization$379.97M

All Metrics

Book Value / Share (Quarterly)$0.63

P/TBV (Annual)28.87x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)21.62%

Cash Flow / Share (Quarterly)$-0.89

Price vs S&P 500 (YTD)-18.32%

Gross Margin (TTM)62.33%

Net Profit Margin (TTM)-71.57%

EPS (TTM)$-1.01

10-Day Avg Trading Volume0.61M

EPS Excl Extra (TTM)$-1.01

Revenue Growth (5Y)23.57%

EPS (Annual)$-0.90

ROI (Annual)-33.13%

Gross Margin (Annual)61.38%

Net Profit Margin (5Y Avg)-77.99%

Cash / Share (Quarterly)$1.19

Revenue Growth QoQ (YoY)42.93%

ROA (Last FY)-26.13%

Revenue Growth TTM (YoY)25.99%

EBITD / Share (TTM)$-0.89

ROE (5Y Avg)-68.81%

Operating Margin (TTM)-65.20%

Cash Flow / Share (Annual)$-0.83

P/B Ratio20.17x

P/B Ratio (Quarterly)14.48x

Net Income / Employee (Annual)$-148,500

EV / Revenue (TTM)9.70x

Net Interest Coverage (TTM)-20.69x

ROA (TTM)-36.98%

EPS Incl Extra (Annual)$-0.90

Current Ratio (Annual)5.91x

Quick Ratio (Quarterly)4.75x

3-Month Avg Trading Volume0.71M

52-Week Price Return5.85%

Revenue / Employee (TTM)$236,100

Tangible BV / Share (Quarterly)$0.18

P/S Ratio (Annual)10.28x

Asset Turnover (Annual)0.38x

52-Week High$30.10

Operating Margin (5Y Avg)-76.68%

EPS Excl Extra (Annual)$-0.90

CapEx CAGR (5Y)1.69%

Tangible BV CAGR (5Y)47.34%

26-Week Price Return-6.22%

Quick Ratio (Annual)4.94x

13-Week Price Return-12.20%

Total Debt / Equity (Annual)1.75x

Current Ratio (Quarterly)5.79x

Enterprise Value$394.02M

Revenue / Share Growth (5Y)10.03%

Asset Turnover (TTM)0.52x

Book Value / Share Growth (5Y)46.87%

Revenue / Employee (Annual)$214,900

Inventory Turnover (Annual)1.88x

Pretax Margin (Annual)-68.93%

Cash / Share (Annual)$1.56

3-Month Return Std Dev99.91%

Gross Margin (5Y Avg)62.85%

Net Income / Employee (TTM)$-169,000

ROE (Last FY)-91.15%

Net Interest Coverage (Annual)-11.31x

EPS Basic Excl Extra (Annual)$-0.90

Receivables Turnover (TTM)5.80x

Total Debt / Equity (Quarterly)2.63x

EPS Incl Extra (TTM)$-1.01

Receivables Turnover (Annual)6.17x

ROI (TTM)-48.60%

P/S Ratio (TTM)9.36x

Pretax Margin (5Y Avg)-77.95%

Revenue / Share (Annual)$1.31

Tangible BV / Share (Annual)$0.48

Price vs S&P 500 (52W)-22.36%

Year-to-Date Return-7.38%

5-Day Price Return10.75%

EPS Normalized (Annual)$-0.90

ROA (5Y Avg)-35.55%

Net Profit Margin (Annual)-69.08%

Month-to-Date Return13.33%

Cash Flow / Share (TTM)$-0.87

EBITD / Share (Annual)$-0.85

Operating Margin (Annual)-65.36%

LT Debt / Equity (Annual)1.75x

ROI (5Y Avg)-47.67%

LT Debt / Equity (Quarterly)2.63x

EPS Basic Excl Extra (TTM)$-1.01

P/TBV (Quarterly)50.33x

P/B Ratio (Annual)14.52x

Inventory Turnover (TTM)2.02x

Pretax Margin (TTM)-71.46%

Book Value / Share (Annual)$0.95

Price vs S&P 500 (13W)-21.94%

Beta1.29x

P/FCF (Annual)60.22x

Revenue / Share (TTM)$1.37

ROE (TTM)-140.96%

52-Week Low$8.27

vGradeF

gGradeA

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.32est. -0.28

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.13

4.22

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
CLPTClearPoint Neuro, Inc. Common Stock	F	A	C	$12.64
SYKStryker Corporation	C	C	D	$299.46
MMM3M Company	C	F	C	$150.93
BSXBoston Scientific Corp.	C	B	F	$47.98
MDLNMedline Inc. Class A common stock	C	D	D	$35.75
BDXBecton, Dickinson and Co.	B	C	C	$145.33
DXCMDexCom, Inc.	C	B	C	$74.87
RMDResMed Inc.	B	B	D	$186.44
WSTWest Pharmaceutical Services, Inc.	D	C	B	$316.30
SOLVSolventum Corporation	C	D	C	$75.84
PENPenumbra, Inc.	F	C	C	$318.95

About

ClearPoint Neuro develops and commercializes minimally invasive surgical platforms for brain and cardiac procedures guided by real-time MRI imaging. The company's flagship ClearPoint system is currently in commercial use and addresses a significant market need for precise, image-guided neurosurgery. Revenue is generated through system sales, services, disposables, and software solutions.